Astrana Health Posts 56% Revenue Surge on Full-Risk Contract Expansion
Event summary
- Astrana Health reported $965.1M in Q1 2026 revenue, up 56% YoY, with adjusted EBITDA growing 82% to $66.3M.
- 80% of Care Partners capitation revenue and 40% of consolidated membership now in full-risk arrangements.
- Free cash flow surged 372% YoY to $64.1M, with net leverage declining to 2.3x.
- Foothill Regional Medical Center won Healthgrades' 2026 Patient Safety Excellence Award for the fourth consecutive year.
The big picture
Astrana Health's strong Q1 2026 results reflect its strategic pivot toward full-risk contracts, positioning it as a leader in value-based care. The company's AI-driven platform and longitudinal patient relationships are key differentiators in an increasingly dynamic healthcare environment. With net leverage declining ahead of schedule, Astrana is well-positioned to capitalize on the shift toward integrated care delivery and financial accountability.
What we're watching
- Risk Model Scaling
- Whether Astrana can sustain its 80% full-risk capitation revenue growth while maintaining cost efficiency.
- AI Integration
- How the company's AI-powered workflows will translate into long-term clinical and economic value.
- Operational Leverage
- The pace at which Astrana can expand its delegated full-risk model beyond Texas.
Related topics